These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Use of proflavine-sensitized poliovirus strains for determination of the range of susceptible animals. Koroleva GA; Lashkevich VA; Voroshilova MK Acta Virol; 1973 Jul; 17(4):310-8. PubMed ID: 4148211 [No Abstract] [Full Text] [Related]
23. Use of nonhuman primates for assaying tumorigenicity of viral-vaccine cell substrates. Petricciani JC; Martin DP Transplant Proc; 1974 Jun; 6(2):189-92. PubMed ID: 4208755 [No Abstract] [Full Text] [Related]
24. Veterinary vaccines. LaSalle B Natl Cancer Inst Monogr; 1968 Dec; 29():515-22. PubMed ID: 4305439 [No Abstract] [Full Text] [Related]
25. Newer methods for assaying efficacy and safety of canine biologics. Hejl JM J Am Vet Med Assoc; 1970 Jun; 156(12):1782-5. PubMed ID: 5422527 [No Abstract] [Full Text] [Related]
26. The need for a standardised cell substrate for virus vaccine production. Perkins FT Jpn J Med Sci Biol; 1971 Oct; 24(5):329-35. PubMed ID: 5003824 [No Abstract] [Full Text] [Related]
27. New recommendations for simultaneous administration of live virus vaccines. Reeve AM J Iowa Med Soc; 1973 Feb; 63(2):50 passim. PubMed ID: 4687453 [No Abstract] [Full Text] [Related]
29. Experience with an established cell line for veterinary vaccine production. Brown AL Natl Cancer Inst Monogr; 1968 Dec; 29():523-6. PubMed ID: 4305440 [No Abstract] [Full Text] [Related]
30. Prospects for a rubella virus vaccine. Parkman PD; Meyer HM Prog Med Virol; 1969; 11():80-106. PubMed ID: 4984711 [No Abstract] [Full Text] [Related]
32. Viral flora of chick and duck tissue sources--discussion. Witter RL Natl Cancer Inst Monogr; 1968 Dec; 29():119-21. PubMed ID: 4888927 [No Abstract] [Full Text] [Related]
33. Delayed dermal hypersensitivity following killed measles vaccine. Experience in 9-month-old infants. Lennon RG; Isacson P J Pediatr; 1967 Oct; 71(4):525-9. PubMed ID: 4963178 [No Abstract] [Full Text] [Related]
34. Rabies vaccine: a century of development from rabbit's spinal cord to genetic engineering. Thongcharoen P; Wasi C J Med Assoc Thai; 1985 Jul; 68(7):388-93. PubMed ID: 3932575 [No Abstract] [Full Text] [Related]
35. General characteristics of enhanced plague formation by poliovirus in poxvirus-infected cells. Tsuchiya Y; Tagaya I J Gen Virol; 1972 Mar; 14(3):229-35. PubMed ID: 4336518 [No Abstract] [Full Text] [Related]
36. Vaccines produced in heteroploid cell lines--discussion. Hull RN Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366 [No Abstract] [Full Text] [Related]
37. Preliminary attempts to detect interactions between coliphages and two attenuated vaccine viruses. Petricciani JC; Meyer BC; Vallancourt RJ; Duryea WJ J Biol Stand; 1975; 3(4):335-40. PubMed ID: 810489 [No Abstract] [Full Text] [Related]
38. Studies on live rubella vaccine. I. Propagation of rubella virus in developing chick embryos and its laboratory characterization. Okuno Y; Minekawa Y; Suzuki N; Takahashi M Biken J; 1968 Dec; 11(4):235-42. PubMed ID: 4976546 [No Abstract] [Full Text] [Related]
39. A2-Hong Kong influenza virus infection and lipid changes in primary human and other cell types. De Sousa CP; Filipe MI Acta Virol; 1972 Jun; 16(1):17-24. PubMed ID: 4110512 [No Abstract] [Full Text] [Related]
40. Vaccines produced in diploid cell lines. Ikić D Natl Cancer Inst Monogr; 1968 Dec; 29():485-93. PubMed ID: 4976866 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]